Dr. Alison Porter first joined Lonza in 1998 where she spent 13 years working in the Cell Culture Process Development Group. In 2011, she joined Fujifilm Diosynth Biotechnologies as Head of the Mammalian Cell Culture R&D Department and led the development of the company’s mammalian expression platform. Alison re-joined Lonza in 2016 as Head of Process Development Sciences (PDS). The PDS group give global support and guidance for technical challenges and questions that arise at any stage in the production of biotherapeutics within Lonza. She now serves as the Head of Expression System Sciences, a role that includes providing in-depth scientific and technical leadership to those working with Lonza’s GS Gene Expression System®. Alison specializes in gene expression systems and the development of recombinant cell lines. She holds a Ph.D. in Biotechnology from the University of Manchester.